Pharma Focus Asia

TFF Pharmaceuticals Plans to Expand R&D Operations Facility in Texas, USA

TFF Pharmaceuticals, Inc plans to expand its R & D opeartions with the opening of new Austin facility located in Texas, USA.


The new research and development facility constructed with an area covering 3,500 square feet will increase the total lab space. The new lab designed with Thin Film Freezing (TFF) technology will be completely dedicated for the manufacturing of products and thus complementing the company’s current formulation development capabilities.

The facility remains as a central hub for research operations. The product development team will also be expanded at the new facility to meet the growing number of partnered projects.

The construction of the new R & D facility is laid to meet the raising demand of thin film freezing technology and product development services. Moreover, the facility allows to boost the testing capabilities to enable larger number of feasibility studies, including a focus on biologics and also meets the growing demand for thin film freezing-based products.


NameTFF Pharmaceuticals, Inc
TypeNew Construction
Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Adopting the Power of AI to Drug Development ProjectsROUQETTE - Pharma Virtual LabDUPHAT 2024Asia Healthcare Week 20247th Annual Pharma Project & Portfolio Management 2024CHEMICAL INDONESIA 2024INALAB 2024The Drug Safety Symposium 2024
Charles river - Endosafe Trillium